Robust
analytics: our
strategic approach

We take a different approach.
We don’t start with the method. We start with the decision.
We believe this is the right place to start.
We begin with the specific decision that the evidence needs to support and the requirements against which it will be assessed.
Advanced methodologies such as matching-adjusted indirect comparisons (MAIC), fractional polynomial models or the integration of real-world evidence (RWE) are therefore not the starting point. They are selected according to the decision context, the statistical challenge and the uncertainty that needs to be resolved.
Our three-step approach
Assessment context
Understand the context
before defining the
analysis.
We first establish the decision context in which the evidence will be assessed.
Statistical focus
Identify
areas of bias and
uncertainty.
We then identify the statistical questions that frame the key evidence issues.
Method selection
Select the
method that fits the
evidence question.
We then select the methodology that best addresses the evidence question.
From decision to analysis
Decision context
↓
Statistical focus
↓
Method selection
↓
Robust evidence
The method is the consequence, not the starting point.
Why this approach matters
Statistical quality is not only about whether an analysis is technically correct.
It is also about whether the analysis:
- addresses the relevant decision question
- reflects the available evidence appropriately
- makes its assumptions transparent
- characterises bias and uncertainty clearly
- remains interpretable under critical review

Robust evidence connects three things:
Explore robust analytics

Indirect comparisons
MAIC, ML-NMR and STC for comparative evidence without head-to-head data.

Real-World Evidence
Designing and analysing RWD to complement clinical evidence.

Evidence synthesis
Connecting evidence across studies and data sources for complex comparative questions.

Statistical modelling
Survival analysis, extrapolation and advanced models for long-term outcomes.

Uncertainty analysis
Characterising assumptions, limitations and uncertainty through sensitivity analyses.

Clinical trial analysis
Analysing treatment effects, subgroups and endpoints across clinical studies.
Our work in practice
Selected examples of complex statistical questions and how we addressed them across clinical development, HTA and market access.
Over 1,000 projects delivered.
Numerus invented a new MAIC methodology
Hyper complex NMA successfully executed
Your next evidence challenge
Have an evidence question?




